Filtros de búsqueda

Lista de obras de

A Never Ending STORI.

artículo científico publicado en 2018

A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease

artículo científico publicado en 2001

A phase I study of visilizumab, a humanized anti-CD3 monoclonal antibody, in severe steroid-refractory ulcerative colitis

artículo científico publicado en 2007

A randomised, double-blind, sham-controlled study of granulocyte/monocyte apheresis for moderate to severe Crohn's disease

artículo científico publicado en 2012

A randomized, double-blind, sham-controlled study of granulocyte/monocyte apheresis for active ulcerative colitis

artículo científico publicado en 2008

A randomized, placebo-controlled, phase II study of tetomilast in active ulcerative colitis

scientific article published on 18 November 2006

A review of activity indices and efficacy end points for clinical trials of medical therapy in adults with ulcerative colitis

artículo científico publicado en 2006

A review of activity indices and efficacy endpoints for clinical trials of medical therapy in adults with Crohn's disease

artículo científico publicado en 2002

A simple classification of Crohn's disease: Report of the Working Party for the World Congresses of Gastroenterology, Vienna 1998

artículo científico publicado en 2007

AGA technical review on perianal Crohn’s disease ⬇️

artículo científico publicado el 1 de noviembre de 2003

AST-120 (spherical carbon adsorbent) in the treatment of perianal fistulae in mild-to-moderate Crohn's disease: FHAST-1, a phase 3, multicenter, placebo-controlled study

artículo científico publicado en 2014

Abatacept for Crohn's disease and ulcerative colitis

artículo científico publicado en 2012

Adalimumab for induction of clinical remission in moderately to severely active ulcerative colitis: results of a randomised controlled trial

artículo científico publicado en 2011

Adalimumab for maintenance of clinical response and remission in patients with Crohn's disease: the CHARM trial

artículo científico publicado en 2006

Adalimumab induction therapy for Crohn disease previously treated with infliximab: a randomized trial

artículo científico publicado en 2007

American Gastroenterological Association Institute technical review on the use of thiopurines, methotrexate, and anti-TNF-α biologic drugs for the induction and maintenance of remission in inflammatory Crohn's disease

artículo científico publicado en 2013

American gastroenterological association consensus development conference on the use of biologics in the treatment of inflammatory bowel disease, June 21-23, 2006.

artículo científico publicado en 2007

Aminosalicylate therapy in the prevention of dysplasia and colorectal cancer in ulcerative colitis

artículo científico publicado en 2006

An evidence-based systematic review on medical therapies for inflammatory bowel disease

artículo científico publicado en 2011

An open-label study of the human anti-TNF monoclonal antibody adalimumab in subjects with prior loss of response or intolerance to infliximab for Crohn's disease

artículo científico publicado en 2004

Are dysplasia and colorectal cancer endoscopically visible in patients with ulcerative colitis?

artículo científico publicado en 2007

Assessment of Peri-Polyp Biopsies of Flat Mucosa in Patients with Inflammatory Bowel Disease

artículo científico publicado en 2018

Assessment of variables associated with smoking cessation in Crohn's disease

artículo científico publicado en 2012

Azathioprine and 6-mercaptopurine for the prevention of postoperative recurrence in Crohn's disease: a meta-analysis

artículo científico publicado en 2009

Best of DDW 2002. Highlights from the 2002 Digestive Disease Week. May 19-22, 2002, San Francisco, CA

artículo científico publicado en 2002

Best of DDW 2006

scientific article published on 01 January 2006

Briakinumab for treatment of Crohn's disease: results of a randomized trial

artículo científico publicado en 2015

Budesonide CIR capsules (once or twice daily divided-dose) in active Crohn's disease: a randomized placebo-controlled study in the United States

artículo científico publicado en 2002

Budesonide for maintenance of remission in patients with Crohn's disease in medically induced remission: a predetermined pooled analysis of four randomized, double-blind, placebo-controlled trials

artículo científico publicado en 2005

Ciprofloxacin for the prevention of postoperative recurrence in patients with Crohn's disease: a randomized, double-blind, placebo-controlled pilot study

artículo científico publicado en 2013

Clinical scenarios in IBD: Optimizing the use of conventional and biologic agents ⬇️

artículo científico publicado el 1 de diciembre de 2010

Colectomy rate comparison after treatment of ulcerative colitis with placebo or infliximab

artículo científico publicado en 2009

Combination Therapy With Infliximab and Azathioprine Improves Infliximab Pharmacokinetic Features and Efficacy: A Post Hoc Analysis

artículo científico publicado en 2018

Comment on 'anti-adhesion therapies and the rule of 3 for rare events'.

artículo científico publicado en 2014

Comparative analysis of the in vitro prosecretory effects of balsalazide, sulfasalazine, olsalazine, and mesalamine in rabbit distal ileum

artículo científico publicado en 2005

Comparison of scheduled and episodic treatment strategies of infliximab in Crohn's disease

scientific article published on 01 February 2004

Complications of peristomal recurrence of Crohn's disease: a case report and a review of literature

artículo científico

Continuous Therapy With Certolizumab Pegol Maintains Remission of Patients With Crohn's Disease for up to 18 Months

artículo científico publicado en 2010

Crohn's is not a 6-week disease: lifelong management of mild to moderate Crohn's disease

artículo científico publicado en 2004

Defining Disease Severity in Inflammatory Bowel Diseases: Current and Future Directions

artículo científico publicado en 2016

Defining complex contributions of NOD2/CARD15 gene mutations, age at onset, and tobacco use on Crohn's disease phenotypes

artículo científico publicado en 2003

Defining the optimal response criteria for the Crohn's disease activity index for induction studies in patients with mildly to moderately active Crohn's disease

artículo científico publicado en 2008

Delayed-release oral mesalamine 4.8 g/day (800-mg tablet) is effective for patients with moderately active ulcerative colitis

artículo científico publicado en 2009

Delayed-release oral mesalamine at 4.8 g/day (800 mg tablet) for the treatment of moderately active ulcerative colitis: the ASCEND II trial

artículo científico publicado en 2005

Design issues and outcomes in IBD clinical trials

artículo científico publicado en 2005

Developing an instrument to assess the endoscopic severity of ulcerative colitis: the Ulcerative Colitis Endoscopic Index of Severity (UCEIS)

artículo científico publicado en 2011

Development of Entrustable Professional Activities for Advanced Inflammatory Bowel Disease Fellowship Training in the United States

artículo científico publicado en 2020

Development of an index to define overall disease severity in IBD.

artículo científico publicado en 2016

Early mucosal healing with infliximab is associated with improved long-term clinical outcomes in ulcerative colitis

artículo científico publicado en 2011

Effects of vedolizumab induction therapy for patients with Crohn's disease in whom tumor necrosis factor antagonist treatment failed

artículo científico publicado en 2014

Efficacy of biological therapies in inflammatory bowel disease: systematic review and meta-analysis

scientific article published on 15 March 2011

Efficacy of topical 5-aminosalicylates in preventing relapse of quiescent ulcerative colitis: a meta-analysis.

artículo científico publicado en 2011

Emerging Treatment Options in Mild to Moderate Ulcerative Colitis

artículo científico publicado en 2015

Emerging issues in ulcerative colitis and ulcerative proctitis: individualizing treatment to maximize outcomes.

artículo científico publicado en 2009

Erratum: Corrigendum: The London Position Statement of the World Congress of Gastroenterology on Biological Therapy for IBD With the European Crohn's and Colitis Organization: When to Start, When to Stop, Which Drug to Choose and How to Predict Respo

article

Evidence for an inflammatory bowel disease locus on chromosome 3p26: linkage, transmission/disequilibrium and partitioning of linkage

article

Evolving Considerations for Thiopurine Therapy for Inflammatory Bowel Diseases-A Clinical Practice Update: Commentary

scientific article published on 07 September 2018

Executive Summary of 'Development of Entrustable Professional Activities for Advanced Inflammatory Bowel Disease Fellowship Training in the United States'

scientific article published on 20 August 2020

Extracorporeal photopheresis for the treatment of refractory Crohn's disease: results of an open-label pilot study

artículo científico publicado en 2009

Factors associated with the development of intestinal strictures or obstructions in patients with Crohn's disease

scientific article published on 01 May 2006

Fecal lactoferrin is a sensitive and specific marker in identifying intestinal inflammation

scientific article published on 01 June 2003

Fever and right upper quadrant pain in a pregnant woman at 30 weeks' gestation

artículo científico publicado en 2004

Histologic Normalization Occurs in Ulcerative Colitis and Is Associated With Improved Clinical Outcomes.

artículo científico publicado en 2017

Human Placenta-derived Cells (PDA-001) for the Treatment of Moderate-to-severe Crohn's Disease: A Phase 1b/2a Study

artículo científico publicado en 2015

Human anti-tumor necrosis factor monoclonal antibody (adalimumab) in Crohn's disease: the CLASSIC-I trial

artículo científico publicado en 2006

IM-UNITI: Three-year Efficacy, Safety, and Immunogenicity of Ustekinumab Treatment of Crohn's Disease

scientific article published on 01 January 2020

In memoriam

artículo científico publicado en 2012

In memoriam: Dr Joseph Barnett Kirsner

artículo científico publicado en 2012

Incidence and importance of antibody responses to infliximab after maintenance or episodic treatment in Crohn's disease

artículo científico publicado en 2004

Incidence and predictors of clinical response, re-induction dose, and maintenance dose escalation with certolizumab pegol in Crohn's disease

artículo científico publicado en 2014

Inflammation is an independent risk factor for colonic neoplasia in patients with ulcerative colitis: a case-control study.

scientific article published on 17 July 2013

Inflammatory bowel disease characteristics among African Americans, Hispanics, and non-Hispanic Whites: characterization of a large North American cohort

artículo científico publicado en 2006

Infliximab Reduces Endoscopic, but Not Clinical, Recurrence of Crohn's Disease After Ileocolonic Resection

artículo científico publicado en 2016

Infliximab for induction and maintenance therapy for ulcerative colitis

artículo científico publicado en 2005

Infliximab in the treatment of Crohn's disease: a user's guide for clinicians

artículo científico publicado en 2002

Interpreting Registrational Clinical Trials of Biological Therapies in Adults with Inflammatory Bowel Diseases

artículo científico publicado en 2016

Joseph Barnett Kirsner, MD, PhD.

artículo científico publicado en 2012

Joseph Barnett Kirsner, MD, PhD.

artículo científico publicado en 2012

Long-term efficacy and safety of ustekinumab for Crohn's disease through the second year of therapy.

artículo científico publicado en 2018

Long-term infliximab maintenance therapy for ulcerative colitis: the ACT-1 and -2 extension studies

scientific article published on 11 April 2011

Long-term safety of adalimumab in clinical trials in adult patients with Crohn's disease or ulcerative colitis.

artículo científico publicado en 2017

Long-term treatment of patients with a history of ulcerative colitis who develop gastritis and pan-enteritis after colectomy

artículo científico publicado en 2013

Maintaining remissions across the lifespan: a roundtable discussion with Crohn's disease experts

artículo científico publicado en 2004

Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial

artículo científico publicado en 2002

Maintenance therapy with certolizumab pegol for Crohn's disease

artículo científico publicado en 2007

Management of Crohn's disease in adults

artículo científico publicado en 2001

Management of Crohn's disease in adults.

artículo científico publicado en 2009

Natalizumab Induction and Maintenance Therapy for Crohn's Disease

artículo científico publicado en 2005

O-001 A Multicenter, Double-Blind, Placebo-Controlled Phase3 Study of Ustekinumab, a Human IL-12/23P40 mAB, in Moderate-Service Crohnʼs Disease Refractory to Anti-TFNα

Open-label study of adalimumab in patients with ulcerative colitis including those with prior loss of response or intolerance to infliximab

artículo científico publicado en 2009

Outcome after surveillance of low-grade and indefinite dysplasia in patients with ulcerative colitis

artículo científico publicado en 2010

Ozanimod Induction and Maintenance Treatment for Ulcerative Colitis

artículo científico publicado en 2016

Perspectives of Clinicians in the United States and Europe on Monitoring Levels of Biologic Agents in Patients Receiving Biologic Therapies for Inflammatory Bowel Diseases

artículo científico publicado en 2019

Phenotype-stratified genetic linkage study demonstrates that IBD2 is an extensive ulcerative colitis locus.

artículo científico publicado en 2006

Pilot feasibility studies of leukocytapheresis with the Adacolumn Apheresis System in patients with active ulcerative colitis or Crohn disease.

artículo científico publicado en 2006

Placebo response rate in clinical trials of fistulizing Crohn's disease: systematic review and meta-analysis ⬇️

artículo científico

Postinduction serum infliximab trough level and decrease of C-reactive protein level are associated with durable sustained response to infliximab: a retrospective analysis of the ACCENT I trial

artículo científico publicado en 2014

Postoperative maintenance of Crohn's disease remission with 6-mercaptopurine, mesalamine, or placebo: a 2-year trial

artículo científico publicado en 2004

Practical application of anti-TNF therapy for luminal Crohn's disease

scientific article published on 18 February 2011

Predictors of adalimumab dose escalation in patients with Crohn's disease at a tertiary referral center

artículo científico publicado en 2011

Prospective randomized open-label multicenter phase I/II dose escalation trial of visilizumab (HuM291) in severe steroid-refractory ulcerative colitis

artículo científico publicado en 2010

Quality indicators for inflammatory bowel disease: development of process and outcome measures

artículo científico

Randomised clinical trial: efficacy, safety and dosage of adjunctive allopurinol in azathioprine/mercaptopurine nonresponders (AAA Study).

artículo científico publicado en 2018

Rapid Changes in Laboratory Parameters and Early Response to Adalimumab: A Pooled Analysis From Patients With Ulcerative Colitis in Two Clinical Trials

scientific article published on 01 September 2019

Reassessing the risks and benefits of thiopurines in Crohn's disease

artículo científico publicado en 2013

Refining the role of TNF antagonists for Crohn's disease. Introduction

artículo científico publicado en 2007

Reinduction with Certolizumab Pegol in Patients with Crohn's Disease Experiencing Disease Exacerbation: 7-Year Data from the PRECiSE 4 Study

artículo científico publicado en 2016

Reinduction with certolizumab pegol in patients with relapsed Crohn's disease: results from the PRECiSE 4 Study

artículo científico publicado en 2010

Reliability and initial validation of the ulcerative colitis endoscopic index of severity

artículo científico publicado en 2013

Remission in patients with Crohn's disease is associated with improvement in employment and quality of life and a decrease in hospitalizations and surgeries.

artículo científico publicado en 2004

Rifaximin for the treatment of active pouchitis: a randomized, double-blind, placebo-controlled pilot study

scientific article published on 01 October 2007

Risk of Biologic Therapy-Associated Progressive Multifocal Leukoencephalopathy: Use of the JC Virus Antibody Assay in the Treatment of Moderate-to-Severe Crohn's Disease

artículo científico publicado en 2012

Rosiglitazone for active ulcerative colitis: a randomized placebo-controlled trial

artículo científico publicado en 2007

Safety and effectiveness of long-term allopurinol-thiopurine maintenance treatment in inflammatory bowel disease

artículo científico publicado en 2013

Safety and tolerability of concurrent natalizumab treatment for patients with Crohn's disease not in remission while receiving infliximab.

artículo científico publicado en 2007

Safety and tolerability of human placenta-derived cells (PDA001) in treatment-resistant crohn's disease: a phase 1 study

artículo científico publicado en 2013

Scheduled maintenance treatment with infliximab is superior to episodic treatment for the healing of mucosal ulceration associated with Crohn's disease

scientific article published on 01 March 2006

Segmental Histologic Normalisation Occurs in Ulcerative Colitis but does not Improve Clinical Outcomes

artículo científico publicado en 2020

Shared experiences and best practices in the management of rheumatoid arthritis and Crohn's disease

artículo científico publicado en 2011

Smoking and inflammatory bowel disease

artículo científico publicado en 2007

Superior mesenteric vein thrombosis after colectomy in a patient with Crohn's disease

artículo científico publicado en 2005

T1192 A Randomized Trial of Metabolite-Adjusted Versus Weight-Based Dosing of Azathioprine (AZA) in Crohn's Disease (CD) [Clinicaltrials. Gov Identifier Nct00113503]

artículo científico publicado en 2009

Tacrolimus for the treatment of fistulas in patients with Crohn's disease: a randomized, placebo-controlled trial

artículo científico publicado en 2003

The Crohn's Disease-Ulcerative Colitis Clinical Appraisal

artículo científico publicado en 2016

The Impact of Clinical Information on the Assessment of Endoscopic Activity: Characteristics of the Ulcerative Colitis Endoscopic Index Of Severity [UCEIS].

artículo científico publicado en 2015

The London Position Statement of the World Congress of Gastroenterology on Biological Therapy for IBD with the European Crohn's and Colitis Organization: when to start, when to stop, which drug to choose, and how to predict response?

artículo científico publicado en 2010

The effects of infliximab therapy on health-related quality of life in ulcerative colitis patients.

artículo científico publicado en 2007

The state of the art in the management of inflammatory bowel disease.

artículo científico publicado en 2003

Time to Symptom Resolution in Ulcerative Colitis With Multimatrix Mesalazine Treatment: A Pooled Analysis

artículo científico publicado en 2020

Tofacitinib Induction Therapy Reduces Symptoms Within 3 Days for Patients With Ulcerative Colitis

scientific article published on 10 September 2018

Treat to target: a proposed new paradigm for the management of Crohn's disease

artículo científico

Treating beyond symptoms with a view to improving patient outcomes in inflammatory bowel diseases

artículo científico publicado en 2014

Treatment of Crohn's disease: the "long" of it

scientific article published on 01 June 2005

Two brothers with skewed thiopurine metabolism in ulcerative colitis treated successfully with allopurinol and mercaptopurine dose reduction

artículo científico publicado en 2011

Ulcerative colitis and ex-smoking: The later the diagnosis, the greater the burden

scholarly article by Jeffrey A. Tuvlin et al published April 2003 in Gastroenterology

Unemployment and disability in patients with moderately to severely active Crohn's disease

artículo científico publicado en 2005

Using Proactive Therapeutic Drug Monitoring of Anti-Tumor Necrosis Factor Therapy in Inflammatory Bowel Disease: From an Old Concept to a Future Standard of Care?

artículo científico publicado en 2018

Ustekinumab as Induction and Maintenance Therapy for Crohn’s Disease

artículo científico publicado en 2016

Ustekinumab induction and maintenance therapy in refractory Crohn's disease

artículo científico publicado en 2012

Vedolizumab as induction and maintenance therapy for Crohn's disease

artículo científico publicado en 2013

Vedolizumab as induction and maintenance therapy for ulcerative colitis

artículo científico publicado en 2013

What changes in inflammatory bowel disease management can be implemented today?

artículo científico

miR-143 and miR-145 are downregulated in ulcerative colitis: putative regulators of inflammation and protooncogenes

artículo científico publicado en 2011

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda